SCHEMBL7308062

SCHEMBL7308062

O=C1CCC(c2ccc(N3CC(COCc4ccccc4)OC3=O)cc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 18/20 0.50
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7308070 1.00 GRM2 (0.50) GRM2LMNA
SCHEMBL2823472 0.85 GRM2 (0.68) GRM2LMNA
SCHEMBL11233634 0.83 GRM2 (0.58) GRM2LMNA
SCHEMBL7314032 0.83 GRM2 (0.43) GRM2
SCHEMBL7314041 0.83 GRM2 (0.43) GRM2
SCHEMBL5618256 0.82 GRM2 (0.48) GRM2
SCHEMBL5617534 0.82 GRM2 (0.48) GRM2
SCHEMBL5617531 0.82 GRM2 (0.48) GRM2
SCHEMBL11230811 0.81 GRM2 (0.65) GRM2
SCHEMBL27325072 0.78 LMNA (0.38) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0657440-B1 Oxazolidine-2-one derivatives as MAO inhibitors HOFFMANN LA ROCHE (CH) 2000-04-05 EP disclosed
US-5574055-A COGNITIVE AND NEURODEGENERATIVE DISORDERS HOFFMANN-LA ROCHE INC. (US) 1996-11-12 US disclosed
EP-0657440-A1 Oxazolidine-2-one derivatives F. HOFFMANN-LA ROCHE AG (CH) 1995-06-14 EP disclosed